medroxyprogesterone acetate has been researched along with Obesity, Morbid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agarwal, R; Ge, M; Hernandez, G; Lopez, C; Segall-Gutierrez, P; Stanczyk, FZ | 1 |
Azen, S; Liu, X; Mishell, DR; Segall-Gutierrez, P; Stanzcyk, F; Taylor, D | 1 |
Du, J; Ge, M; Mizraji, K; Niu, C; Segall-Gutierrez, P; Stanczyk, FZ; Tilley, I | 1 |
2 trial(s) available for medroxyprogesterone acetate and Obesity, Morbid
Article | Year |
---|---|
Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously.
Topics: Adult; Body Mass Index; Contraceptive Agents, Female; Delayed-Action Preparations; Estradiol; Female; Humans; Immunoassay; Injections, Subcutaneous; Medroxyprogesterone Acetate; Obesity; Obesity, Morbid; Ovarian Follicle; Ovulation; Ovulation Inhibition; Progesterone; Progestins; Severity of Illness Index; Young Adult | 2010 |
Effect of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) on serum androgen markers in normal-weight, obese, and extremely obese women.
Topics: Adult; Androgen Antagonists; Androgens; Androstane-3,17-diol; Androstenedione; Biomarkers; Body Mass Index; Contraceptive Agents, Female; Dehydroepiandrosterone Sulfate; Drug Implants; Female; Humans; Medroxyprogesterone Acetate; Obesity; Obesity, Morbid; Sex Hormone-Binding Globulin; Subcutaneous Tissue; Testosterone; Time Factors; Young Adult | 2012 |
1 other study(ies) available for medroxyprogesterone acetate and Obesity, Morbid
Article | Year |
---|---|
A pilot study examining short-term changes in bone mineral density among class 3 obese users of depot-medroxyprogesterone acetate.
Topics: Absorptiometry, Photon; Adult; Body Composition; Body Mass Index; Bone Density; Case-Control Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Estradiol; Estrogens; Female; Humans; Injections, Subcutaneous; Medroxyprogesterone Acetate; Obesity, Morbid; Overweight; Pilot Projects; Progesterone Congeners; Time Factors; Young Adult | 2013 |